Learn / BMRN
NASDAQ: BMRN
Biomarin Pharmaceutical (BMRN) stock, explained like you're 5
Biomarin Pharmaceutical trades on the Nasdaq under the ticker BMRN. It is a large cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 10.6 billion dollars.
- Ticker
- BMRN
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Large cap, about 10.6 billion dollars
Is Biomarin Pharmaceutical a small, medium or large cap company?
Yes. Biomarin Pharmaceutical is a large cap stock. Its market cap, which is the total value of all its shares, is about 10.6 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Biomarin Pharmaceutical makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves BMRN stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- BioMarin Pharmaceutical Inc. (BMRN) Stock Forecasts (Yahoo Finance)
- Why is BioMarin Pharmaceutical stock gaining today? (Investing.com)
- BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN) Screens as a Decent Value Stock on Cheap Forward Earnings (ChartMill)
- BMRN Stock Rises On Up To $490M Alesta Deal, But Analyst Cuts Price Target To $59 Here’s Why (Stocktwits)
- 1cBio Received Shareholder Proceeds Upon Closing of BioMarin Pharmaceutical Inc.'s Acquisition of Alesta Therapeutics (Yahoo Finance)
Follow BMRN in your daily brief
Each trading day at 5 PM ET we post what happened to Biomarin Pharmaceutical and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow BMRN
Questions about Biomarin Pharmaceutical stock
What does Biomarin Pharmaceutical do?
Biomarin Pharmaceutical trades on the Nasdaq under the ticker BMRN. It is a large cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 10.6 billion dollars.
What is the ticker symbol for Biomarin Pharmaceutical?
Biomarin Pharmaceutical trades under the ticker BMRN on the Nasdaq.
What is Biomarin Pharmaceutical's market cap?
Biomarin Pharmaceutical is a large cap stock with a market cap of about 10.6 billion dollars.
How does Biomarin Pharmaceutical make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves BMRN stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow BMRN stock every day?
Add BMRN to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.